This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In Response:
We thank Dr Cerit for the question he poses regarding the association between syntax scores and outcomes in the PIONEER trial (An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment …
American Heart Association Professional?
Log in with your Professional Heart Daily username and password. Not an American Heart Association Professional? Continue below.
Log in using your username and password
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
This Issue
Article Tools
Share this Article
- Response by Gibson and Fox to Letter Regarding Article, “Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy”Permalink:
